Int J Gynaecol Obstet. 2021 Aug 21. doi: 10.1002/ijgo.13895. Online ahead of print.
ABSTRACT
OBJECTIVE: To evaluate the role of hydrosalpinx in the susceptibility of chronic endometritis (CE).
METHODS: This is a retrospective cohort study, which includes 624 patients with hydrosalpinx (group A) and 789 patients without hydrosalpinx (group B) undergoing laparoscopy and hysteroscopy simultaneously. Endometrial morphology was recorded under hysteroscopy. Endometrial biopsy was obtained after hysteroscopy, and immunohistochemical staining for syndecan-1 (CD138) was carried out.
RESULTS: No significantly statistical differences were found between the two groups when comparing the incidence of endometrial hyperemia or endometrial micro-polyps under hysteroscopy (P>0.05). Hydrosalpinx had a significant impact on the incidence of CE (P<0.05) (plasma cell count: no plasma cells: OR 0.71, 95% CI 0.58-0.88, P=0.002; ≥1/HPF: OR 1.40, 95% CI 1.14-1.74, P=0.002; ≥3/HPF: OR 1.50, 95% CI 1.18-1.91, P=0.001; ≥5/HPF: OR 1.62, 95% CI 1.27-2.21, P<0.001). There were no significant differences in the comparison of plasma cell count between the unilateral hydrosalpinx group (274 patients) and the bilateral hydrosalpinx group (350 patients) (P>0.05).
CONCLUSION: The presence of hydrosalpinx increased the incidence of CE. Bilateral hydrosalpinx did not significantly increase the incidence of CE compared with unilateral hydrosalpinx.
PMID:34418100 | DOI:10.1002/ijgo.13895
